THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
Balance Sheet
Fiscal Year Start:
Oct 1
Assets in 2024 (Year End)
$148,610,558
Property, Plant, & Equipment (net)
34%
Investments
20%
Receivables (Non-Related)
19%
Other Assets
14%
Cash & Equivalents
12%
Prepaid Expenses
1%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2024 (Year End)
$52,983,880
Notes Payable / Debt (Non-Related)
62%
Payables & Accruals
26%
Deferred Revenue
9%
Other Liabilities
3%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$17,033,429
$18,093,745
+6%
Receivables (Non-Related)
$10,408,539
$28,683,292
+176%
Related-Party Receivables
$0
$0
-
Inventories
$0
$0
-
Prepaid Expenses
$2,774,586
$1,731,813
-38%
Investments
$41,118,193
$30,213,272
-27%
Property, Plant, & Equipment (net)
$56,193,240
$49,808,326
-11%
Other Assets
$17,627,344
$20,080,110
+14%
Total Assets
$145,155,331
$148,610,558
+2%
Liabilities
2023
2024
Change
Payables & Accruals
$8,165,819
$14,005,960
+72%
Grants Payable
$0
$0
-
Deferred Revenue
$1,611,782
$4,784,639
+197%
Tax-Exempt Bond Liabilities
$0
$0
-
Custodial & Escrow Liabilities
$0
$0
-
Notes Payable / Debt (Non-Related)
$43,674,178
$32,587,887
-25%
Related-Party Payables
$0
$0
-
Other Liabilities
$1,274,661
$1,605,394
+26%
Total Liabilities
$54,726,440
$52,983,880
-3%
Net assets
2023
2024
Change
Restricted Net Assets
N/A
N/A
N/A
Unrestricted Net Assets
N/A
N/A
N/A
Net assets
2023
2024
Change
Net assets
+$90,428,891
+$95,626,678
+6%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)